These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6273629)

  • 1. Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats.
    Komori T; Yamamoto K
    Jpn J Pharmacol; 1981 Jun; 31(3):401-7. PubMed ID: 6273629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor of angiotensin I converting enzyme: (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (YS-980).
    Funae Y; Komori T; Sasaki D; Yamamoto K
    Biochem Pharmacol; 1980 Jun; 29(11):1543-7. PubMed ID: 6249321
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
    Nakata K; Takada T; Yamauchi H; Iso T
    Eur J Pharmacol; 1986 Feb; 121(2):293-5. PubMed ID: 3009208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
    Nakata K; Nishimura K; Takada T; Ikuse T; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):305-10. PubMed ID: 2437397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive rats.
    Unger T; Rockhold RW; Schaz K; Vescel P; Bönner G; Rascher W; Ganten D
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():157s-160s. PubMed ID: 232020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
    Nishimura K; Miyazaki M; Okunishi H; Toda N
    Jpn J Pharmacol; 1987 Apr; 43(4):379-87. PubMed ID: 3039218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
    Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J
    Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
    Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
    J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.
    Unger T; Rockhold RW; Bönner G; Rascher W; Schaz K; Speck G; Schömig A; Ganten D
    Clin Exp Hypertens (1978); 1981; 3(1):121-40. PubMed ID: 6258887
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats.
    Abe Y; Sakamoto W; Fukui K; Iwao H; Takada T; Yamamoto K
    Arch Int Pharmacodyn Ther; 1988; 292():237-47. PubMed ID: 3395170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
    DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
    Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
    Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
    Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihypertensive effects of SA446, hydralazine and the combination on renal hypertensive rats and spontaneously hypertensive rats by long-term treatment].
    Nakata K; Nishimura K; Takada T; Yamauchi H; Iso T
    Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):113-21. PubMed ID: 3699625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
    Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
    Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of single and repeated oral administration of MK-421 and captopril on blood pressures in normotensive and experimental hypertensive rats].
    Ohmura I; Maki E; Naruse T; Chen CS; Ikeda N; Asami T
    Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):293-302. PubMed ID: 3002925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
    Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):401-4. PubMed ID: 3038402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.